Arunjyoti Bio Ventures Ltd Stock Price Today (NSE: ABVL)
Fundamental Score
Arunjyoti Bio Ventures Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Arunjyoti Bio Ventures Ltd share price today is ₹6.43, up +0.64% on NSE/BSE as of 30 March 2026. Arunjyoti Bio Ventures Ltd (ABVL) is a Small-cap company in the Other Financial Services sector with a market capitalisation of ₹140.90 (Cr). The 52-week high for ABVL share price is ₹13.80 and the 52-week low is ₹5.05. The company has a Return on Equity (ROE) of -10.66% and a debt-to-equity ratio of 0.71.
Arunjyoti Bio Ventures Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Arunjyoti Bio Ventures Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Arunjyoti Bio Ventures Share Price: A Financial Analysis
The Other Financial Services sector, often overlooked, plays a critical role in providing niche financial solutions. Many companies lack strong operating cash flow, making their valuation sensitive to debt levels. This financial analysis examines the current standing of the Arunjyoti Bio Ventures share price, currently trading at ₹7.78, and its key financial metrics. This analysis is part of a larger, 80-parameter fundamental audit verified by Sweta Mishra, and relies solely on observational data. We avoid any buy or sell recommendations.
A significant observation is the absence of a Price-to-Earnings (PE) ratio for Arunjyoti Bio Ventures Ltd. This typically indicates that the company is either not profitable or earnings are not stable enough to provide a meaningful valuation metric. The Return on Capital Employed (ROCE) stands at 4.03%. ROCE is a crucial metric indicating how efficiently a company utilizes its capital to generate profits. A low ROCE, like the one observed here, suggests the company is not generating significant returns from its investments which directly impacts the strength of its economic moat (competitive advantage).
When assessing Arunjyoti Bio Ventures Ltd within its peer group, comparisons are essential. Considering
Sumedha Fiscal Services Ltd, one crucial aspect is management quality and their respective track records in capital allocation. Without explicitly comparing, we observe that consistent and prudent investment decisions are key factors driving sustained value creation in the financial services sector. Investors often carefully scrutinize management decisions as they directly affect profitability and shareholder value.The 4.03% ROCE directly influences the perceived strength of Arunjyoti Bio Ventures' competitive advantage. In general, a higher ROCE indicates a wider economic moat, as the company is able to generate superior returns compared to its peers. A lower ROCE, as observed here, suggests that the company may face challenges in maintaining or expanding its market share, and the moat may be relatively narrow. This could be due to factors like intense competition, lower pricing power, or inefficient operations. Continued monitoring of financial performance is crucial to understanding the long-term viability of Arunjyoti Bio Ventures Ltd.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Arunjyoti Bio Ventures Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of ABVL across key market metrics for learning purposes.
Positive Indicators
2 factors identified
Consistent Growth Track Record (32.84% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
7 factors identified
Below-Average Return on Equity (-10.66%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (4.03%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Profit Decline Concern (-459.09%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Revenue Contraction (-15.91%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Weak Interest Coverage (0.59x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
Negative Free Cash Flow (₹-54.08 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Arunjyoti Bio Ventures Ltd Financial Statements
Comprehensive financial data for Arunjyoti Bio Ventures Ltd including income statement, balance sheet and cash flow
About ABVL (Arunjyoti Bio Ventures Ltd)
Arunjyoti Bio Ventures Ltd is a dynamic entity operating within the Other Financial Services sector, leveraging its unique position to foster growth and innovation. While its roots... are firmly planted in traditional financial instruments, the company is steadily expanding its portfolio to include investments in sustainable and ecologically responsible ventures. Based in Hyderabad, India, ABVL is committed to identifying and nurturing emerging businesses that demonstrate a commitment to both profitability and environmental stewardship. With a focus on strategic partnerships and long-term value creation, Arunjyoti Bio Ventures aims to be a catalyst for positive change, driving financial returns while contributing to a more sustainable future. Their approach is marked by careful due diligence and a commitment to supporting ventures throughout their lifecycle. ABVL differentiates itself through a keen understanding of the evolving financial landscape, particularly the growing importance of Environmental, Social, and Governance (ESG) factors. The company's investment philosophy centers on identifying opportunities that align with global sustainability goals, recognizing that responsible investing is not only ethically sound but also economically advantageous in the long run. They employ a team of experienced professionals with expertise in financial analysis, venture capital, and sustainable business practices. This combination of skills allows them to thoroughly assess the potential of various ventures, providing not only capital but also strategic guidance and operational support. ABVL's commitment extends beyond mere financial investment, emphasizing a collaborative approach to foster lasting success. Originally established in 1986 as Century 21st Portfolio Limited, Arunjyoti Bio Ventures underwent a strategic transformation in 2014, signaling a renewed focus on bio-related and sustainable ventures. This evolution reflects the company's proactive approach to adapting to changing market dynamics and embracing emerging opportunities. With a strong foundation built on years of financial experience, ABVL is well-positioned to navigate the complexities of the modern investment landscape. The company's commitment to innovation and its emphasis on long-term value creation make it a compelling partner for businesses seeking both financial support and strategic guidance. By bridging the gap between financial expertise and sustainable business practices, Arunjyoti Bio Ventures aims to shape a more prosperous and environmentally responsible future.
Company Details
Key Leadership
ABVL Share Price: Frequently Asked Questions
What is the current share price of Arunjyoti Bio Ventures Ltd (ABVL)?
As of 30 Mar 2026, 12:03 pm IST, Arunjyoti Bio Ventures Ltd share price is ₹6.43. The ABVL stock has a market capitalisation of ₹140.90 (Cr) on NSE/BSE.
Is ABVL share price Overvalued or Undervalued?
ABVL share price is currently trading at a P/E ratio of 0.00x, compared to the industry average of 30.94x. Based on this relative valuation, the Arunjyoti Bio Ventures Ltd stock appears to be Fairly Valued against its sector peers.
What is the 52-week high and low of ABVL share price?
The 52-week high of ABVL share price is ₹13.80 and the 52-week low is ₹5.05. These values are updated daily from NSE/BSE price data.
What factors affect the Arunjyoti Bio Ventures Ltd share price?
Key factors influencing ABVL share price include quarterly earnings growth (Sales Growth: -15.91%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Arunjyoti Bio Ventures Ltd a good stock for long-term investment?
Arunjyoti Bio Ventures Ltd shows a 5-year Profit Growth of N/A% and an ROE of -10.66%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.71 before investing in ABVL shares.
How does Arunjyoti Bio Ventures Ltd compare with its industry peers?
Arunjyoti Bio Ventures Ltd competes with major peers in the Other Financial Services. Investors should compare ABVL share price P/E of 0.00x and ROE of -10.66% against the industry averages to determine competitive standing.
What is the P/E ratio of ABVL and what does it mean?
ABVL share price has a P/E ratio of N/Ax compared to the industry average of 30.94x. Investors pay ₹N/A for every ₹1 of annual earnings.
How is ABVL performing according to Bull Run's analysis?
ABVL has a Bull Run fundamental score of 18.9/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does ABVL belong to?
ABVL operates in the Other Financial Services industry. This classification helps understand the competitive landscape and sector-specific trends affecting Arunjyoti Bio Ventures Ltd share price.
What is Return on Equity (ROE) and why is it important for ABVL?
ABVL has an ROE of -10.66%, which suggests challenges in generating returns from shareholders equity. ROE measures how efficiently Arunjyoti Bio Ventures Ltd generates profits from shareholders capital.
How is ABVL debt-to-equity ratio and what does it indicate?
ABVL has a debt-to-equity ratio of 0.71, which indicates moderate leverage that should be monitored.
What is ABVL dividend yield and is it a good dividend stock?
ABVL offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Arunjyoti Bio Ventures Ltd shares.
How has ABVL share price grown over the past 5 years?
ABVL has achieved 5-year growth rates of: Sales Growth 32.84%, Profit Growth N/A%, and EPS Growth N/A%.
What is the promoter holding in ABVL and why does it matter?
Promoters hold 47.64% of ABVL shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Arunjyoti Bio Ventures Ltd.
What is ABVL market capitalisation category?
ABVL has a market capitalisation of ₹141 crores, placing it in the Small-cap category.
How volatile is ABVL stock?
ABVL has a beta of N/A. A beta > 1 suggests the Arunjyoti Bio Ventures Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is ABVL operating profit margin trend?
ABVL has a 5-year average Operating Profit Margin (OPM) of 13.45%, indicating the company's operational efficiency.
How is ABVL quarterly performance?
Recent quarterly performance shows Arunjyoti Bio Ventures Ltd YoY Sales Growth of -15.91% and YoY Profit Growth of -459.09%.
What is the institutional holding pattern in ABVL?
ABVL has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the Arunjyoti Bio Ventures Ltd stock.